HTLV-1 Envelope Protein
Spezies: Human T-lymphotropic Virus (HTLV)
Wirt: Escherichia coli (E. coli)
Recombinant
Protein is >95 % pure (as determined by HPLC-C4, and 10 % PAGE).
ELISA, WB
-
- Target
- HTLV-1 Envelope
- Protein-Typ
- Recombinant
- Spezies
- Human T-lymphotropic Virus (HTLV)
- Quelle
- Escherichia coli (E. coli)
- Applikation
- ELISA, Western Blotting (WB)
- Spezifität
- This protein is immunoreactive with all sera of HTLV-I and HTLV-II infected individuals with antibody response to HTLV envelope.
- Reinheit
- Protein is >95 % pure (as determined by HPLC-C4, and 10 % PAGE).
-
- Applikationshinweise
- Use this protein as an antigen in ELISA and western Blots. It makes an excellent reagent in the correct detection of HTLV infections. It shows minimal specificity problems.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- 1 mg/mL in 10 mM Na-PO4, pH 6.0, containing 0.1 % SDS, and 1 mM DTT, final concentration: 1 mg per vial
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C. Keep container tightly closed. The protein will remain stable for five years if stored frozen and for six months in solution if stored in solution at 4 °C.
- Haltbarkeit
- 60 months
-
- Target
- HTLV-1 Envelope
- Substanzklasse
- Viral Protein
- Hintergrund
-
Human T-Lymphocyte Virus (HTLV)-1 Envelope contains the C- terminus of gp46 and most of p21E of HTLV-I. This non-fusion, E. coli-derived protein starts from HIV-1 env. amino acid 165, and ends in amino acid 440. Human T-cell Leukaemia Virus Type I (HTLV-I) is a retrovirus that causes adult T-cell leukaemia (ATL).
Synonyms: rHTLV-I, HTLVI envelope, HTLV-1 envelope, HTLV1 envelope
-
Sie sind hier:
